vs
Side-by-side financial comparison of MMTec, Inc. (MTC) and Picard Medical, Inc. (PMI). Click either name above to swap in a different company.
Picard Medical, Inc. is the larger business by last-quarter revenue ($1.2M vs $807.5K, roughly 1.5× MMTec, Inc.). Picard Medical, Inc. runs the higher net margin — -878.3% vs -5749.7%, a 4871.3% gap on every dollar of revenue.
MMTec, Inc. is a global fintech enterprise that develops and delivers integrated trading technology solutions, including high-performance trading platforms, real-time market data services, and risk management systems. Its core clients cover brokerage firms, asset management institutions, and professional traders across North America and the Asia-Pacific region, helping financial market participants boost trading efficiency and operational security.
MTC vs PMI — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $807.5K | $1.2M |
| Net Profit | $-46.4M | $-10.4M |
| Gross Margin | 83.5% | -11.0% |
| Operating Margin | -189.7% | -293.8% |
| Net Margin | -5749.7% | -878.3% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-1.84 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $1.2M | ||
| Q2 25 | $807.5K | $2.1M |
| Q3 25 | — | $-10.4M | ||
| Q2 25 | $-46.4M | $-6.7M |
| Q3 25 | — | -11.0% | ||
| Q2 25 | 83.5% | -6.0% |
| Q3 25 | — | -293.8% | ||
| Q2 25 | -189.7% | -165.2% |
| Q3 25 | — | -878.3% | ||
| Q2 25 | -5749.7% | -315.5% |
| Q3 25 | — | — | ||
| Q2 25 | $-1.84 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.2M | $2.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-19.8M | $8.0M |
| Total Assets | $20.3M | $13.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $2.8M | ||
| Q2 25 | $10.2M | $410.0K |
| Q3 25 | — | $8.0M | ||
| Q2 25 | $-19.8M | $-54.5M |
| Q3 25 | — | $13.5M | ||
| Q2 25 | $20.3M | $11.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-6.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-6.5M | ||
| Q2 25 | $-1.7M | $-4.8M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MTC
Segment breakdown not available.
PMI
| Products | $1.1M | 94% |
| Other | $72.0K | 6% |
